Clinical Trials Browser

Phase 3 × OTHER × Gefitinib × Clear all

NCT01951469 2022-03-08

Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02893332 2021-02-03

Sindas

Phase 3 Terminated

Stage IV EGFR Mutated Non-Small Cell Lung Cancer

NCT01405079 2020-02-18

ADJUVANT

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04028778 2019-11-08

FL-ALTER

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02929693 2019-04-11

Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma

Phase 3 Unknown

Neoplasms

NCT03656393 2018-09-04

RCTACSCNSCLC

Phase 3 Unknown

NSCLC

NCT02714010 2017-10-27

EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01404260 2017-01-27

ISCAN

Phase 3 Completed

219 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT02824458 2016-07-07

A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations

Phase 3 Unknown

EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors

NCT01158170 2010-07-08

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01066195 2010-02-10

Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung